17β-estradiol replacement reverses age-related lung disease in estrogen-deficient C57BL/6J mice

Endocrinology

Volumn 155, Issue 2, 2014, Pages 441-448

  Glassberg, Marilyn K ^a   Choi, Rhea ^a   Manzoli, Vita ^a   Shahzeidi, Shahriar ^a   Rauschkolb, Peter ^b   Voswinckel, Robert ^b   Aliniazee, Muddassir ^a   Xia, Xiaomei ^a   Elliot, Sharon J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE;

AGE RELATED LUNG DISEASE; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; LUNG; LUNG DISEASE; LUNG PARENCHYMA; LUNG VOLUME; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGING; ANIMALS; APOPTOSIS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN REPLACEMENT THERAPY; FEMALE; LUNG; LUNG DISEASES; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; ORGAN SIZE; OVARIECTOMY; RNA, MESSENGER;

EID: 84893190736     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1345     Document Type: Article

References (49)

1. Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Respir J. 1999;13: 197-205.
2. Verbeken EK, Cauberghs M, Mertens I, Clement J, Lauweryns JM, Van de Woestijne KP. The senile lung. Comparison with normal and emphysematous lungs. 2. Functional aspects. Chest. 1992;101: 800-809.
3. Verbeken EK, Cauberghs M, Mertens I, Clement J, Lauweryns JM, Van de Woestijne KP. The senile lung. Comparison with normal and emphysematous lungs. 1. Structural aspects. Chest. 1992;101: 793-799.
4. Huang K, Rabold R, Schofield B, Mitzner W, Tankersley CG. Agedependent changes of airway and lung parenchyma in C57BL/6J mice. J Appl Physiol. 2007;102: 200-206.
5. Massaro D, Clerch LB, Massaro GD. Estrogen receptor-α regulates pulmonary alveolar loss and regeneration in female mice: morphometric and gene expression studies. Am J Physiol Lung Cell Mol Physiol. 2007;293:L222-L228.
6. Morani A, Warner M, Gustafsson JA. Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues. J Intern Med. 2008;264: 128-142.
7. Hall JM, McDonnell DP. The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulatesERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology. 1999;140: 5566-5578.
8. Breeze RG, Wheeldon EB. The cells of the pulmonary airways. Am Rev Respir Dis. 1977;116: 705-777.
9. Couse JF, Lindzey J, Grandien K, Gustafsson JA, Korach KS. Tissue distribution and quantitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) messenger ribonucleic acid in the wild-type and ERα-knockout mouse. Endocrinology. 1997;138: 4613-4621.
10. Morani A, Barros RP, Imamov O, et al. Lung dysfunction causes systemic hypoxia in estrogen receptor β knockout (ERβ-/-) mice. Proc Natl Acad Sci U S A. 2006;103: 7165-7169.
11. Elliot SJ, Karl M, Berho M, et al. Smoking induces glomerulosclerosis in aging estrogen-deficient mice through cross-talk between TGF-β1 and IGF-I signaling pathways. J Am Soc Nephrol. 2006; 17: 3315-3324.
12. vom Saal FS, Finch CE, Nelson JF. Natural history and mechanisms of reproductive aging in humans, laboratory rodents, and other selected vertebrates. In: Knobil E, Neill JD, eds. The Physiology of Reproduction. 2nd ed. New York: Raven Press; 1994: 1213-1314.
13. Shahzeidi S, Sarnstrand B, Jeffery PK, McAnulty RJ, Laurent GJ. Oral N-acetylcysteine reduces bleomycin-induced collagen deposition in the lungs of mice. Eur Respir J. 1991;4: 845-852.
14. Scherle W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie. 1970;26: 57-60.
15. Hyde DM, Tyler NK, Putney LF, Singh P, Gundersen HJ. Total number and mean size of alveoli in mammalian lung estimated using fractionator sampling and unbiased estimates of the Euler characteristic of alveolar openings. Anat Rec A Discov Mol Cell Evol Biol. 2004;277: 216-226.
16. Fehrenbach H, Voswinckel R, Michl V, et al. Neoalveolarisation contributes to compensatory lung growth following pneumonectomy in mice. Eur Respir J. 2008;31: 515-522.
17. Fehrenbach H. Animal models of pulmonary emphysema: a stereologist's perspective. Eur Respir Rev. 2006;15: 136-147.
18. Glassberg MK, Elliot SJ, Fritz J, et al. Activation of the estrogen receptor contributes to the progression of pulmonary lymphangioleiomyomatosis via matrix metalloproteinase-induced cell invasiveness. J Clin Endocrinol Metab. 2008;93: 1625-1633.
19. Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem. 1996;29: 225-229.
20. Kassira N, Glassberg MK, Jones C, et al. Estrogen deficiency and tobacco smoke exposure promote matrix metalloproteinase-13 activation in skin of aging B6 mice. Ann Plast Surg. 2009;63: 318-322.
21. Potier M, Elliot SJ, Tack I, et al. Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J Am Soc Nephrol. 2001;12: 241-251.
22. Schiffer M, Bitzer M, Roberts IS, et al. Apoptosis in podocytes induced by TGF-β and Smad7. J Clin Invest. 2001;108: 807-816.
23. Ramos JW. The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int J Biochem Cell Biol. 2008;40: 2707-2719.
24. Wright JL, Cosio MG, Churg A. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2008; 295:L1-L15.
25. Miller RD, Hepper NG, Kueppers F, Gordon H, Offord KP. Host factors in chronic obstructive pulmonary disease in an upper Midwest rural community. Design, case selection, and clinical characteristics in a matched-pair study. Mayo Clin Proc. 1976;51: 709-715.
26. Ringbaek T, Seersholm N, Viskum K. Standardised mortality rates in females and males with COPD and asthma. Eur Respir J. 2005; 25: 891-895.
27. Song Y, Klevak A, Manson JE, Buring JE, Liu S. Asthma, chronic obstructive pulmonary disease, and type 2 diabetes in the Women's Health Study. Diabetes Res Clin Pract. 2010;90: 365-371.
28. Verma MK, Miki Y, Sasano H. 2011 Sex steroid receptors in human lung diseases. J Steroid Biochem Mol Biol. 2011;127: 216-222.
29. Tam A, Morrish D, Wadsworth S, Dorscheid D, Man SF, Sin DD. The role of female hormones on lung function in chronic lung diseases. BMC Womens Health. 2011;11:24.
30. Patrone C, Cassel TN, Pettersson K, et al. Regulation of postnatal lung development and homeostasis by estrogen receptorβ. Mol Cell Biol. 2003;23: 8542-8552.
31. Stabile LP, Siegfried JM. Estrogen receptor pathways in lung cancer. Curr Oncol Rep. 2004;6: 259-267.
32. Massaro D, Massaro GD. Estrogen regulates pulmonary alveolar formation, loss, and regeneration in mice. Am J Physiol Lung Cell Mol Physiol. 2004;287:L1154-L1159.
33. Vanderbilt JN, Miesfeld R, Maler BA, Yamamoto KR. Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol Endocrinol. 1987;1: 68-74.
34. Webb P, Lopez GN, Greene GL, Baxter JD, Kushner PJ. The limits of the cellular capacity to mediate an estrogen response. Mol Endocrinol. 1992;6: 157-167.
35. Catanuto P, Doublier S, Fornoni A, et al. 17β-Estradiol and tamoxifen upregulate estrogen receptorβ expression and control podocyte signaling pathways in a model of type 2 diabetes. Kidney Int. 2009; 75: 1194-1201.
36. Saceda M, Lippman ME, Chambon P, et al. Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol. 1988; 2: 1157-1162.
37. Elliot S, Catanuto P, Fernandez P, et al. Subtype specific estrogen receptor action protects against changes in MMP-2 activation in mouse retinal pigmented epithelial cells. Exp Eye Res. 2008;86: 653-660.
38. Lei J, Silbiger S, Ziyadeh FN, Neugarten J. Serum-stimulated α1 type IV collagen gene transcription is mediated by TGF-β and inhibited by estradiol. Am J Physiol. 1998;274:F252-F258.
39. Chakrabarti S, Patel KD. Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res. 2005;31: 599-621.
40. Ito K, Barnes PJ.COPDas a disease of accelerated lung aging. Chest. 2009;135: 173-180.
41. Suki B, Ito S, Stamenovic D, Lutchen KR, Ingenito EP. Biomechanics of the lung parenchyma: critical roles of collagen and mechanical forces. J Appl Physiol. 2005;98: 1892-1899.
42. Lee HC, Wei YH. Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging. Exp Biol Med (Maywood). 2007;232: 592-606.
43. Loft S, Vistisen K, Ewertz M, Tjønneland A, Overvad K, Poulsen HE. OxidativeDNAdamage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis. 1992;13: 2241-2247.
44. Vogelmeier C, Bals R. Chronic obstructive pulmonary disease and premature aging. Am J Respir Crit Care Med. 2007;175: 1217-1218.
45. Ishii M, Yamaguchi Y, Yamamoto H, Hanaoka Y, Ouchi Y. Airspace enlargement with airway cell apoptosis in Klotho mice: a model of aging lung. J Gerontol A Biol Sci Med Sci. 2008;63: 1289-1298.
46. Torres M, Forman HJ. Redox signaling and the MAP kinase pathways. BioFactors. 2003;17: 287-296.
47. Li LF, Liao SK, Ko YS, Lee CH, Quinn DA. Hyperoxia increases ventilator-induced lung injury via mitogen-activated protein kinases: a prospective, controlled animal experiment. Crit Care. 2007; 11:R25.
48. Umar S, Iorga A, Matori H, et al. Estrogen rescues preexisting severe pulmonary hypertension in rats. Am J Respir Crit Care Med. 2011; 184: 715-723.
49. Maciewicz RA, Warburton D, Rennard SI. Can increased understanding of the role of lung development and aging drive new advances in chronic obstructive pulmonary disease? Proc Am Thorac Soc. 2009;6: 614-617.